Search for a clinical trial
Other search option(s)
11 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Terminated trial = 
; Funded by an IRDiRC member = 
; Member of a ERN = 
National clinical trial(s)
GERMANY
Nordrhein-Westfalen
DÜSSELDORF
PRIMETEST: Phase II Single-arm Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B - DE
Universitätsklinikum Düsseldorf
Klinik für Urologie
SWITZERLAND
Suisse Alémanique
BASEL
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma. A Multicenter, Open Label Phase II Trial With Two Cohorts
Universitätsspital Basel
Tumorzentrum
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors
Cliniques universitaires Saint-Luc - UCLouvain
Cliniques Universitaires Saint-Luc
FRANCE
ILE-DE-FRANCE
VILLEJUIF
AcSé : Secured Access to Pembrolizumab for Adult Patients With Selected Rare Cancer Types (Phase II)
CLCC Institut Gustave Roussy
Département d'Innovation Thérapeutique et d'Essais Précoces
ITALY
LOMBARDIA
MILANO
An Open Label, Randomized, Phase 2 Study of the Anti-Programmed Death-Ligand 1 (PD-L1) Durvalumab, Alone or in Combination With Tremelimumab, in Patients With Advanced and Relapsed Germ Cell Tumors
Fondazione IRCCS Istituto Nazionale dei Tumori
S.C. Oncologia chirurgica urologica
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
An Open-Label, Multicohort, Phase II Study of Atezolizumab in Advanced Solid Tumors (Phase 2) - AT
Institution: Information not provided - AT
ITALY
CAMPANIA
NAPOLI
Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
S.C. Oncologia Medica Uro-Ginecologica
NETHERLANDS
Noord-Holland
AMSTERDAM
The Drug Rediscovery Protocol (DRUP trial): A Dutch National Study on behalf of the Center for Personalized Cancer Treatment (CPCT) to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to determine the Potential Efficacy in Treatment of Advanced Cancers with a Known Molecular Profile (Phase II)
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Afdeling Maag-Darm-Leveroncologie
UNITED KINGDOM
Greater London
LONDON
A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours with Poor Prognosis - GAMMA
St Bartholomew's Hospital, Barts and The London NHS Trust
Department of Medical Oncology
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique
ITALY
LAZIO
ROMA